The role of MITF is well-known in melanoma [47], and recent studies suggest that MITF overexpression in kidney angiomyolipoma cells [48] and clear cell renal cell carcinoma (ccRCC) improve cell growth, proliferation, and invasion in vitro and in vivo [49]. Here, MITF is linked to kidney angiomyolipoma.